I85PREP
⌘ K
PRC Ocular Pharmacologist study materials
PRC Ocular Pharmacologist study resources

PRC Ocular Pharmacologist practice questions

One question at a time. Build your PRC Ocular Pharmacologist understanding.

First 50 of 200 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Ocular Pharmacology

Which ocular hypotensive agent lowers intraocular pressure primarily by increasing aqueous outflow through the uveoscleral pathway?

  1. Brinzolamide
  2. Pilocarpine
  3. Timolol
  4. Latanoprost Correct answer.

Explanation

Prostaglandin F2-alpha analogues such as latanoprost act on FP receptors in the ciliary muscle and sclera, remodeling the extracellular matrix and enhancing uveoscleral outflow. This mechanism is distinct from the trabecular (conventional) route targeted by cholinergics and from aqueous suppression by beta-blockers or carbonic anhydrase inhibitors.

Question 2Ocular Pharmacology

A patient using timolol eye drops develops wheezing and reduced peak flow. Which property of timolol best explains this adverse event?

  1. Direct histamine release from mast cells in the lung
  2. Non-selective beta-adrenergic blockade reaching the bronchial tree Correct answer.
  3. Muscarinic receptor stimulation in the airways
  4. Alpha-1 agonism causing bronchial smooth muscle contraction

Explanation

Timolol blocks both beta-1 and beta-2 receptors, and enough drug is absorbed systemically through the nasolacrimal mucosa to inhibit bronchial beta-2 receptors, precipitating bronchospasm in susceptible patients. Beta-1 selective agents and punctal occlusion reduce but do not eliminate this risk.

Question 3Ocular Pharmacology

Which topical agent is a prodrug that is hydrolyzed in the cornea to a metabolite which then inhibits carbonic anhydrase II in the ciliary epithelium?

  1. Brinzolamide
  2. Bimatoprost
  3. Acetazolamide
  4. Dorzolamide Correct answer.

Explanation

Dorzolamide is formulated as a prodrug (dorzolamide hydrochloride is the salt of the active amine, but the parent molecule is designed for corneal penetration) whose lipophilic form crosses the cornea and is converted to the active carbonic anhydrase inhibitor. Brinzolamide is not a prodrug, and acetazolamide is given systemically.

Question 4Ocular Pharmacology

A 68-year-old with open-angle glaucoma and a history of asthma is started on a topical beta-blocker. Which alternative class avoids bronchospasm while still suppressing aqueous humor formation?

  1. Topical alpha-2 agonist
  2. Topical non-selective beta-blocker
  3. Topical prostaglandin analogue
  4. Topical carbonic anhydrase inhibitor Correct answer.

Explanation

Topical carbonic anhydrase inhibitors such as dorzolamide reduce aqueous secretion by inhibiting carbonic anhydrase in the ciliary epithelium without any beta-adrenergic activity, so they do not provoke bronchospasm. Alpha-2 agonists and prostaglandin analogues also avoid beta-blockade, but the question specifically asks for an aqueous-suppressing class.

Question 5Ocular Pharmacology

Which finding is the most characteristic ocular adverse effect of chronic topical prostaglandin analogue therapy?

  1. Punctate epithelial erosions from preservative toxicity
  2. Angle closure from pupillary block
  3. Increased iris pigmentation and eyelash lengthening Correct answer.
  4. Posterior subcapsular cataract

Explanation

Prostaglandin F2-alpha analogues stimulate melanogenesis in iris melanocytes and prolong the anagen phase of eyelash follicles, producing irreversible iris darkening and hypertrichosis. These effects are cosmetic and are the most frequently reported long-term changes with this class.

Question 6Ocular Pharmacology

A patient on topical pilocarpine reports dim vision and brow ache after each instillation. Which mechanism explains these symptoms?

  1. Ciliary muscle contraction producing accommodative spasm and miosis Correct answer.
  2. Ciliary muscle relaxation producing cycloplegia
  3. Direct toxicity to the corneal endothelium
  4. Pupillary dilation with iris root crowding

Explanation

Pilocarpine is a direct muscarinic agonist that contracts the ciliary muscle, inducing accommodative spasm (brow ache) and miosis, which reduces light entry and causes dim vision, especially in older patients with lens opacity. These effects are expected pharmacologic consequences rather than idiosyncratic toxicity.

Question 7Ocular Pharmacology

Which topical alpha-2 adrenergic agonist is associated with a risk of follicular conjunctivitis and is contraindicated in patients taking monoamine oxidase inhibitors?

  1. Brimonidine
  2. Apraclonidine Correct answer.
  3. Latanoprost
  4. Pilocarpine

Explanation

Apraclonidine is a relatively selective alpha-2 agonist used for short-term IOP control; it carries a notable rate of follicular conjunctivitis and, because it can affect systemic catecholamine handling, is contraindicated with MAO inhibitors. Brimonidine is also an alpha-2 agonist but has a different adverse-effect profile and is less associated with this specific contraindication.

Question 8Ocular Pharmacology

Which topical medication is used to reverse iatrogenic mydriasis and has a mechanism of action as an alpha-2 agonist that inhibits norepinephrine release?

  1. Tropicamide
  2. Cyclopentolate
  3. Apraclonidine Correct answer.
  4. Phenylephrine

Explanation

Apraclonidine, an alpha-2 agonist, can cause miosis by reducing sympathetic tone to the iris dilator through presynaptic inhibition of norepinephrine release. This property has been used off-label to reverse pharmacologic mydriasis.

Question 9Ocular Pharmacology

Which agent is a potent cycloplegic and mydriatic that also carries a risk of systemic anticholinergic toxicity, particularly in children?

  1. Atropine Correct answer.
  2. Brimonidine
  3. Pilocarpine
  4. Timolol

Explanation

Atropine is a non-selective muscarinic antagonist producing prolonged cycloplegia and mydriasis; systemic absorption can cause flushing, tachycardia, and delirium, especially in pediatric patients. Its long duration of action distinguishes it from shorter-acting cycloplegics.

Question 10Ocular Pharmacology

A patient with a shallow anterior chamber receives a topical mydriatic before a dilated fundus examination. Which agent carries the greatest risk of precipitating acute angle closure because of its strong mydriatic effect?

  1. Pilocarpine
  2. Phenylephrine Correct answer.
  3. Latanoprost
  4. Dorzolamide

Explanation

Phenylephrine is a direct alpha-1 agonist that contracts the iris dilator muscle, producing mydriasis and iris root crowding that can precipitate angle closure in anatomically predisposed eyes. Cholinergic agonists, prostaglandin analogues, and carbonic anhydrase inhibitors do not dilate the pupil.

Question 11Ocular Pharmacology

Which topical ophthalmic formulation is designed to increase corneal contact time by converting from a liquid to a gel upon instillation?

  1. Timolol gel-forming solution Correct answer.
  2. Pilocarpine solution
  3. Timolol aqueous solution
  4. Brimonidine solution

Explanation

Gel-forming solutions contain polymers that undergo a sol-to-gel transition on contact with the tear film, prolonging precorneal residence time and improving bioavailability. This formulation strategy reduces dosing frequency compared with conventional aqueous solutions.

Question 12Ocular Pharmacology

Which pharmacokinetic property of the cornea limits the ocular absorption of highly lipophilic drugs?

  1. The hydrophilic stroma acts as a barrier to lipophilic molecules Correct answer.
  2. The tear film metabolizes all lipophilic drugs
  3. The epithelium is impermeable to all drugs
  4. The endothelium actively secretes drugs into the anterior chamber

Explanation

The cornea is a trilamellar structure with a lipophilic epithelium and endothelium surrounding a hydrophilic stroma. Highly lipophilic drugs partition well into the epithelium but poorly into the aqueous stroma, limiting overall transcorneal permeation, which is why optimal ocular drugs require a balance of lipophilicity and hydrophilicity.

Question 13Ocular Pharmacology

Which preservative commonly used in multidose ophthalmic solutions is associated with corneal epithelial toxicity in patients using multiple drops daily?

  1. Sodium hyaluronate
  2. Hydroxypropyl methylcellulose
  3. Sodium chloride
  4. Benzalkonium chloride Correct answer.

Explanation

Benzalkonium chloride is a quaternary ammonium preservative that disrupts epithelial cell membranes and tight junctions with cumulative exposure, contributing to punctate keratopathy and reduced tear film stability. Preservative-free formulations are preferred in patients with severe dry eye or frequent dosing.

Question 14Ocular Pharmacology

Punctal occlusion after instilling eye drops reduces systemic absorption by which mechanism?

  1. Increasing corneal epithelial permeability
  2. Enhancing hepatic first-pass metabolism
  3. Reducing tear film turnover
  4. Decreasing drainage into the nasolacrimal duct and nasal mucosa Correct answer.

Explanation

Most of an instilled drop drains through the nasolacrimal duct to the highly vascular nasal mucosa, where drug enters the systemic circulation and bypasses hepatic first-pass metabolism. Occluding the punctum for a few minutes retains the drug on the ocular surface and reduces this systemic uptake.

Question 15Ocular Pharmacology

Which topical ophthalmic drug is a mast cell stabilizer used prophylactically for allergic conjunctivitis and has a relatively slow onset?

  1. Prednisolone acetate
  2. Ketorolac
  3. Sodium cromoglycate Correct answer.
  4. Olopatadine

Explanation

Sodium cromoglycate stabilizes mast cells and prevents degranulation, so it must be used before allergen exposure to be effective; it does not relieve acute symptoms. Dual-acting agents such as olopatadine combine antihistamine and mast-cell effects with faster relief.

Question 16Ocular Pharmacology

A patient with allergic conjunctivitis needs rapid relief of itching and redness. Which topical agent provides both antihistamine and mast cell stabilizing activity?

  1. Sodium cromoglycate
  2. Naphazoline
  3. Olopatadine Correct answer.
  4. Lodoxamide

Explanation

Olopatadine is an H1-receptor antagonist with additional mast cell stabilizing properties, giving rapid symptom relief plus prophylaxis. Pure mast cell stabilizers such as cromoglycate and lodoxamide lack immediate antihistamine action, and decongestants such as naphazoline provide only vasoconstriction.

Question 17Ocular Pharmacology

Which topical non-steroidal anti-inflammatory drug is used to prevent intraoperative miosis during cataract surgery by inhibiting prostaglandin synthesis?

  1. Atropine
  2. Flurbiprofen sodium Correct answer.
  3. Latanoprost
  4. Pilocarpine

Explanation

Topical NSAIDs such as flurbiprofen inhibit cyclooxygenase and reduce prostaglandin-mediated iris sphincter contraction, helping maintain intraoperative mydriasis. Prostaglandin analogues such as latanoprost would have the opposite effect on the pupil.

Question 18Ocular Pharmacology

Which corticosteroid formulation has the greatest ocular penetration and is most likely to raise intraocular pressure when used chronically?

  1. Loteprednol etabonate
  2. Prednisolone phosphate solution
  3. Fluorometholone
  4. Prednisolone acetate suspension Correct answer.

Explanation

Prednisolone acetate is a suspension with high lipophilicity and good corneal penetration, producing strong intraocular anti-inflammatory effect but also a high risk of steroid-induced ocular hypertension. Fluorometholone and loteprednol are designed for reduced IOP elevation.

Question 19Ocular Pharmacology

A patient using chronic topical prednisolone acetate for uveitis develops elevated intraocular pressure. Which mechanism best explains steroid-induced ocular hypertension?

  1. Increased aqueous humor production by the ciliary epithelium
  2. Pupillary block from iris sphincter contraction
  3. Increased resistance to aqueous outflow at the trabecular meshwork Correct answer.
  4. Reduced uveoscleral outflow from ciliary muscle relaxation

Explanation

Corticosteroids alter trabecular meshwork extracellular matrix and cytoskeleton, increasing outflow resistance and raising IOP in susceptible individuals. Aqueous production is generally not increased and may even be reduced.

Question 20Ocular Pharmacology

Which topical antiviral is a thymidine analogue that requires phosphorylation by viral thymidine kinase to inhibit viral DNA polymerase in herpes simplex keratitis?

  1. Acyclovir
  2. Ganciclovir
  3. Trifluridine Correct answer.
  4. Idoxuridine

Explanation

Trifluridine is a fluorinated pyrimidine nucleoside analogue that is phosphorylated intracellularly and incorporated into viral DNA, inhibiting replication; it is a first-line topical treatment for epithelial herpes simplex keratitis. Acyclovir and ganciclovir act by different phosphorylation pathways.

Question 21Ocular Pharmacology

Which topical antibiotic is a fluoroquinolone commonly used for bacterial keratitis and inhibits bacterial DNA gyrase?

  1. Ciprofloxacin Correct answer.
  2. Erythromycin
  3. Bacitracin
  4. Polymyxin B

Explanation

Ciprofloxacin is a fluoroquinolone that inhibits DNA gyrase (topoisomerase II) and topoisomerase IV, blocking bacterial DNA replication. It provides broad gram-negative and gram-positive coverage for corneal ulcers.

Question 22Ocular Pharmacology

Which agent is used as a topical chelating agent to treat ocular surface calcification and has a mechanism of binding divalent cations?

  1. Acetylcysteine
  2. Hyaluronidase
  3. Disodium edetate (EDTA) Correct answer.
  4. Sodium citrate

Explanation

Disodium edetate chelates calcium and other divalent cations, dissolving calcareous deposits on the ocular surface such as band keratopathy. Acetylcysteine is a mucolytic, and sodium citrate is used as an anticoagulant or in some formulations but not as a chelator for calcification.

Question 23Ocular Pharmacology

Which topical agent is a cholinergic agonist used to treat accommodation insufficiency and has a longer duration than pilocarpine?

  1. Cyclopentolate
  2. Carbachol Correct answer.
  3. Tropicamide
  4. Atropine

Explanation

Carbachol is a direct cholinergic agonist that is more resistant to acetylcholinesterase than pilocarpine, giving a longer duration of action; it is used for miosis and IOP reduction. Atropine, tropicamide, and cyclopentolate are anticholinergic and cause cycloplegia.

Question 24Ocular Pharmacology

Which topical medication is used to treat vernal keratoconjunctivitis and acts as a selective H1-receptor antagonist with mast cell stabilizing properties?

  1. Cromolyn
  2. Naphazoline
  3. Ketotifen
  4. Epinastine Correct answer.

Explanation

Epinastine is a selective H1-receptor antagonist with mast cell stabilizing activity, used for allergic and vernal conjunctivitis. Ketotifen is also dual-acting but is less selective, and cromolyn is a pure stabilizer.

Question 25Ocular Pharmacology

Which anti-VEGF agent is a recombinant fusion protein that binds both VEGF-A and VEGF-B and is used intravitreally for diabetic macular edema?

  1. Aflibercept Correct answer.
  2. Pegaptanib
  3. Bevacizumab
  4. Ranibizumab

Explanation

Aflibercept is a recombinant fusion protein comprising VEGF receptor extracellular domains fused to an IgG Fc fragment, acting as a soluble decoy receptor for VEGF-A and VEGF-B (and placental growth factor). Ranibizumab and bevacizumab are monoclonal antibody fragments, and pegaptanib is an aptamer.

Question 26Ocular Pharmacology

A 62-year-old man with open-angle glaucoma is started on a topical prostaglandin analogue. Which structural modification of the prostaglandin F2alpha backbone is chiefly responsible for the potent, long-lasting IOP reduction seen with latanoprost?

  1. Esterification of the C-1 carboxyl group to improve corneal penetration
  2. Addition of a phenoxy ring at the omega chain terminus
  3. Saturation of the C-13 double bond to slow metabolic oxidation
  4. Introduction of an aromatic ring at C-17 to increase receptor affinity Correct answer.

Explanation

Latanoprost is an isopropyl ester prodrug whose C-17 aromatic (phenyl) substituent on the omega chain markedly increases affinity for the FP receptor, giving powerful IOP lowering. The ester only aids corneal penetration and is hydrolysed after absorption, so it does not create the intrinsic potency. Saturation of the C-13 double bond and omega-chain phenoxy substitution describe other analogues, not the C-17 modification of latanoprost.

Question 27Ocular Pharmacology

A patient develops marked conjunctival hyperemia and increased iris pigmentation after several months of topical bimatoprost. Which receptor population does bimatoprost primarily engage to lower intraocular pressure?

  1. Muscarinic M3 receptors on the ciliary muscle
  2. FP prostaglandin receptors increasing uveoscleral outflow Correct answer.
  3. Alpha-1 adrenergic receptors on the ciliary epithelium
  4. Beta-2 adrenergic receptors reducing aqueous production

Explanation

Bimatoprost is a prostamide that acts predominantly at FP receptors to enhance uveoscleral outflow, which explains both the IOP reduction and the iris hyperpigmentation and hyperemia. Beta-blockers and alpha agonists reduce aqueous production, while muscarinic agonists act on the ciliary muscle to increase trabecular outflow. The pigmentary change reflects melanocyte stimulation characteristic of FP agonism.

Question 28Ocular Pharmacology

A 70-year-old woman with asthma and a history of bronchospasm is being considered for glaucoma therapy. Which topical agent should be avoided because of its potential to precipitate bronchoconstriction?

  1. Timolol Correct answer.
  2. Dorzolamide
  3. Brimonidine
  4. Travoprost

Explanation

Topical timolol is a nonselective beta-adrenergic antagonist that can reach the systemic circulation and provoke bronchospasm and bradycardia, so it is relatively contraindicated in reactive airway disease. Brimonidine, dorzolamide, and travoprost do not carry this beta-blockade risk. Punctal occlusion reduces but does not eliminate systemic absorption of timolol.

Question 29Ocular Pharmacology

A patient using topical dorzolamide complains of tingling in the fingers and metallic taste. Which enzyme does this drug inhibit to reduce aqueous humor formation?

  1. Cyclooxygenase-2 in the ciliary body
  2. Carbonic anhydrase II in the ciliary epithelium Correct answer.
  3. Sodium-potassium ATPase in the corneal endothelium
  4. Phosphodiesterase-3 in the trabecular meshwork

Explanation

Dorzolamide inhibits carbonic anhydrase II in the ciliary epithelium, reducing bicarbonate secretion and thereby aqueous humor production. The resulting systemic carbonic anhydrase inhibition explains paresthesias and dysgeusia. The other enzymes listed are not the target of topical carbonic anhydrase inhibitors.

Question 30Ocular Pharmacology

A 55-year-old man is prescribed topical apraclonidine before laser trabeculoplasty to prevent a postoperative pressure spike. Which mechanism best explains its IOP-lowering effect?

  1. Increase of trabecular outflow via beta-2 receptor stimulation
  2. Reduction of aqueous production via alpha-2 receptor stimulation Correct answer.
  3. Relaxation of the ciliary muscle via anticholinergic action
  4. Contraction of the ciliary muscle via muscarinic stimulation

Explanation

Apraclonidine is a relatively selective alpha-2 adrenergic agonist that reduces aqueous humor production, making it useful for preventing pressure spikes after laser procedures. It does not stimulate beta-2 receptors or act on muscarinic receptors. Alpha-2 agonism also underlies its use as a diagnostic aid for Horner syndrome.

Question 31Ocular Pharmacology

A patient with a history of sulfonamide allergy is being evaluated for topical therapy. Which agent requires particular caution because of its sulfonamide structural moiety?

  1. Bimatoprost
  2. Brinzolamide Correct answer.
  3. Latanoprost
  4. Pilocarpine

Explanation

Brinzolamide is a sulfonamide derivative, so patients with sulfonamide hypersensitivity may be at risk of cross-reactivity, although topical exposure is low. Latanoprost, bimatoprost, and pilocarpine are not sulfonamides. Clinicians typically weigh the low systemic absorption against the reported allergy.

Question 32Ocular Pharmacology

A patient receiving topical timolol and oral verapamil develops symptomatic bradycardia. Which interaction best explains this event?

  1. Additive suppression of atrioventricular conduction and heart rate Correct answer.
  2. Increased renal clearance of verapamil caused by timolol
  3. Displacement of timolol from plasma protein binding sites
  4. Induction of hepatic metabolism of timolol by verapamil

Explanation

Timolol absorbed systemically blocks beta-1 receptors, and verapamil blocks calcium channels; together they depress sinus node automaticity and atrioventricular conduction, producing bradycardia. Verapamil does not induce timolol metabolism or increase its renal clearance. The interaction is pharmacodynamic rather than pharmacokinetic.

Question 33Ocular Pharmacology

A patient with keratoconus is fitted with a rigid contact lens and prescribed a topical medication to slow disease progression. Which agent is used for this purpose?

  1. Riboflavin with ultraviolet-A exposure Correct answer.
  2. Sodium hyaluronate
  3. Olopatadine
  4. Ketotifen

Explanation

Corneal collagen cross-linking uses riboflavin as a photosensitizer activated by ultraviolet-A light to strengthen corneal collagen and slow keratoconus progression. Sodium hyaluronate is a lubricant, and ketotifen and olopatadine are antiallergic agents. None of the latter alter corneal biomechanics.

Question 34Ocular Pharmacology

A patient with acute angle-closure glaucoma needs rapid reduction of intraocular pressure while awaiting definitive laser therapy. Which intravenous osmotic agent is most appropriate?

  1. Pilocarpine
  2. Dorzolamide
  3. Mannitol Correct answer.
  4. Acetazolamide

Explanation

Intravenous mannitol is an osmotic diuretic that draws fluid from the eye and rapidly lowers IOP in acute angle closure. Acetazolamide, pilocarpine, and dorzolamide are useful adjuncts but are not osmotic agents. Mannitol requires caution in patients with heart failure or renal impairment.

Question 35Ocular Pharmacology

A patient with a history of angle-closure glaucoma is given a topical agent that causes pupil dilation. Which receptor action produces mydriasis without cycloplegia?

  1. Alpha-1 adrenergic stimulation of the iris dilator muscle Correct answer.
  2. Beta-2 stimulation of the ciliary muscle
  3. Alpha-2 stimulation of the ciliary epithelium
  4. Muscarinic antagonism of the iris sphincter

Explanation

Stimulation of alpha-1 receptors on the iris dilator muscle contracts it and produces mydriasis while leaving the ciliary muscle unaffected, so accommodation is preserved. Muscarinic antagonism causes both mydriasis and cycloplegia. Beta-2 and alpha-2 receptors do not mediate pupillary dilation in this manner.

Question 36Ocular Pharmacology

A patient with chronic blepharitis is prescribed topical azithromycin. Which mechanism contributes to its efficacy in meibomian gland dysfunction?

  1. Inhibition of viral DNA polymerase
  2. Chelation of calcium in the tear film
  3. Inhibition of bacterial 50S ribosomal subunit with anti-inflammatory lipid effects Correct answer.
  4. Blockade of fungal ergosterol synthesis

Explanation

Azithromycin binds the 50S ribosomal subunit to inhibit bacterial protein synthesis and also has immunomodulatory and lipid-regulating effects that improve meibomian gland secretion. It does not act on ergosterol, viral DNA polymerase, or calcium chelation. These combined properties support its use in blepharitis and meibomian gland dysfunction.

Question 37Ocular Pharmacology

A patient using topical ciprofloxacin for a corneal ulcer develops a white crystalline corneal deposit. Which property of fluoroquinolones best explains this finding?

  1. Chelation of tear film magnesium causing calcification
  2. Irreversible binding to corneal epithelial DNA
  3. Poor aqueous solubility at neutral pH leading to drug precipitation Correct answer.
  4. Photochemical activation producing free radicals

Explanation

Fluoroquinolone precipitates can form when the drug's solubility falls, particularly with frequent dosing or altered tear pH, producing white crystalline deposits. The mechanism is physicochemical precipitation rather than DNA binding, magnesium chelation, or photoactivation. Reducing dosing frequency or switching agents usually resolves the deposits.

Question 38Ocular Pharmacology

A patient with herpes simplex keratitis is treated with topical ganciclovir gel. Which step distinguishes its mechanism from that of acyclovir?

  1. It directly inhibits viral DNA polymerase without phosphorylation
  2. It acts by inhibiting viral reverse transcriptase
  3. It is phosphorylated by viral protein kinase UL97 rather than thymidine kinase Correct answer.
  4. It requires viral thymidine kinase but not host kinases for activation

Explanation

Ganciclovir is activated by viral UL97 protein kinase and then by host kinases, whereas acyclovir is activated by viral thymidine kinase. Both ultimately inhibit viral DNA polymerase, but the initial activating enzyme differs. Ganciclovir does not act without phosphorylation, and reverse transcriptase is a retroviral target.

Question 39Ocular Pharmacology

A patient with vernal keratoconjunctivitis is started on topical cyclosporine 0.1%. Which mechanism underlies its steroid-sparing effect?

  1. Inhibition of prostaglandin synthesis via cyclooxygenase
  2. Inhibition of calcineurin to block T-cell activation and cytokine release Correct answer.
  3. Blockade of histamine H1 receptors
  4. Direct mast cell degranulation

Explanation

Cyclosporine binds cyclophilin and inhibits calcineurin, blocking T-cell activation and cytokine transcription, which reduces the immune-mediated inflammation of vernal keratoconjunctivitis. It does not degranulate mast cells, block H1 receptors, or inhibit cyclooxygenase. This immunomodulation allows reduction of topical steroid use.

Question 40Ocular Pharmacology

A patient with dry eye disease uses a topical emulsion containing castor oil. Which mechanism best describes the action of this tear substitute?

  1. Blockade of corneal nociceptors to reduce discomfort
  2. Inhibition of matrix metalloproteinases in the stroma
  3. Restoration of the lipid layer to reduce evaporative loss Correct answer.
  4. Stimulation of goblet cell mucin secretion

Explanation

Oil-containing emulsions supplement the lipid layer of the tear film, slowing evaporation and stabilizing the tear film in evaporative dry eye. They do not stimulate goblet cells, block nociceptors, or inhibit matrix metalloproteinases. Aqueous and mucin components address different aspects of tear deficiency.

Question 41Ocular Pharmacology

A patient undergoing cataract surgery receives topical tropicamide and phenylephrine. Which combination of receptor actions produces the desired mydriasis?

  1. Beta-1 agonism plus alpha-2 agonism
  2. Muscarinic antagonism plus beta-2 antagonism
  3. Muscarinic agonism plus alpha-1 antagonism
  4. Muscarinic antagonism plus alpha-1 agonism Correct answer.

Explanation

Tropicamide blocks muscarinic receptors on the iris sphincter, while phenylephrine stimulates alpha-1 receptors on the dilator muscle; together they maximize pupillary dilation. Combining a muscarinic agonist with an alpha-1 antagonist would constrict the pupil. Beta receptors play no role in this pupillary response.

Question 42Ocular Pharmacology

A patient requires a topical anesthetic for tonometry. Which agent is preferred for brief office procedures because of its rapid onset and short duration?

  1. Lidocaine with epinephrine
  2. Proparacaine Correct answer.
  3. Bupivacaine
  4. Tetracaine for long-term use

Explanation

Proparacaine is a short-acting topical ester anesthetic with rapid onset, well suited to brief procedures such as tonometry. Bupivacaine is longer acting and used for regional blocks, while epinephrine-containing lidocaine is not a standard topical ophthalmic choice. Chronic use of any topical anesthetic is avoided because of corneal toxicity.

Question 43Ocular Pharmacology

A patient with a corneal abrasion is prescribed topical diclofenac for pain. Which mechanism explains both the analgesia and the potential for delayed epithelial healing?

  1. Direct blockade of voltage-gated sodium channels
  2. Antagonism of substance P receptors
  3. Cyclooxygenase inhibition reducing prostaglandin synthesis Correct answer.
  4. Lipoxygenase inhibition reducing leukotriene synthesis

Explanation

Diclofenac inhibits cyclooxygenase and lowers prostaglandin synthesis, which reduces pain and inflammation but can impair epithelial repair when used repeatedly on an injured cornea. It does not act through lipoxygenase, sodium channel blockade, or substance P antagonism. This healing concern underlies caution with topical NSAIDs after abrasion.

Question 44Ocular Pharmacology

A patient with a corneal ulcer caused by Pseudomonas aeruginosa is treated with topical tobramycin. Which mechanism accounts for its bactericidal activity?

  1. Binding the 50S subunit to block peptide bond formation
  2. Inhibition of cell wall transpeptidase
  3. Inhibition of DNA gyrase
  4. Binding the 30S ribosomal subunit to cause misreading of mRNA Correct answer.

Explanation

Aminoglycosides such as tobramycin bind the bacterial 30S ribosomal subunit, causing misreading of the genetic code and producing abnormal proteins that kill the organism. They do not bind the 50S subunit, inhibit transpeptidase, or target DNA gyrase. The latter mechanisms describe macrolides, beta-lactams, and fluoroquinolones respectively.

Question 45Ocular Pharmacology

A patient is prescribed topical atropine for anterior uveitis. Which property explains why the effect on the pupil persists for days after a single instillation?

  1. Slow dissociation from muscarinic receptors and slow aqueous turnover Correct answer.
  2. Rapid hepatic first-pass metabolism prolonging local action
  3. Accumulation in the lens with gradual release
  4. Irreversible covalent binding to the sphincter muscle

Explanation

Atropine dissociates slowly from muscarinic receptors in the iris sphincter and ciliary muscle, and the small aqueous volume turns over slowly, so a single dose produces mydriasis and cycloplegia lasting several days. The binding is reversible, and neither hepatic metabolism nor lens accumulation explains the prolonged local effect. This durability is useful in uveitis to prevent synechiae.

Question 46Ocular Pharmacology

A patient with a history of narrow angles is given topical scopolamine for uveitis and develops acute pressure elevation. Which mechanism explains this adverse event?

  1. Reduced uveoscleral outflow from ciliary muscle contraction
  2. Pupillary dilation causing iris apposition to the trabecular meshwork Correct answer.
  3. Swelling of the lens induced by anticholinergic action
  4. Increased aqueous production by the ciliary epithelium

Explanation

Anticholinergic mydriasis dilates the pupil and allows the iris to bunch and appose the trabecular meshwork, precipitating angle closure in predisposed eyes. It does not increase aqueous production or cause lens swelling. The risk is mechanical obstruction of outflow rather than a secretory effect.

Question 47Ocular Pharmacology

A patient with glaucoma uses topical latanoprost and reports increased eyelash length and darkening of the iris. Which mechanism accounts for the eyelash change?

  1. Alpha-2 agonism stimulating the tarsal glands
  2. Carbonic anhydrase inhibition promoting keratinization
  3. FP receptor stimulation altering the hair growth cycle in the eyelid margin Correct answer.
  4. Beta-adrenergic blockade increasing lash density

Explanation

Prostaglandin FP receptor stimulation prolongs the anagen phase of eyelash follicles, producing longer, thicker, darker lashes; the same class causes iris melanocyte pigmentation. Beta blockers, carbonic anhydrase inhibitors, and alpha-2 agonists do not produce this effect. These changes are largely irreversible and should be discussed before starting therapy.

Question 48Ocular Pharmacology

A patient with a prosthetic eye develops giant papillary conjunctivitis from protein deposits on the prosthesis. Which topical agent is most appropriate for reducing the associated allergic inflammation?

  1. Timolol
  2. Atropine
  3. Olopatadine Correct answer.
  4. Pilocarpine

Explanation

Olopatadine is a dual-acting antihistamine and mast cell stabilizer that reduces itching and inflammation in allergic conjunctivitis, including prosthesis-related giant papillary conjunctivitis. Pilocarpine, timolol, and atropine address glaucoma or uveitis and have no antiallergic role. Cleaning the prosthesis remains an important adjunct.

Question 49Ocular Pharmacology

A patient receiving topical prednisolone acetate for severe anterior uveitis is monitored for ocular hypertension. Which mechanism best explains the steroid-induced pressure rise?

  1. Increased aqueous production by the ciliary epithelium
  2. Increased resistance to aqueous outflow at the trabecular meshwork Correct answer.
  3. Blockade of prostaglandin-mediated uveoscleral outflow
  4. Reduced systemic absorption of aqueous humor

Explanation

Corticosteroids induce changes in the trabecular meshwork, including increased extracellular matrix deposition, that raise outflow resistance and elevate IOP in susceptible patients. Aqueous production is generally not increased and may even be reduced. The effect is dose- and duration-dependent and resolves slowly after the steroid is stopped.

Question 50Ocular Pharmacology

A patient with ocular rosacea is prescribed oral doxycycline in addition to lid hygiene. Which property contributes most to its benefit at subantimicrobial doses?

  1. Blockade of histamine H1 receptors in the conjunctiva
  2. Stimulation of meibomian gland lipid synthesis
  3. Inhibition of matrix metalloproteinases and inflammatory cytokine production Correct answer.
  4. Direct antifungal activity against Demodex mites

Explanation

At low doses doxycycline suppresses matrix metalloproteinases and inflammatory cytokines, improving meibomian gland function and ocular rosacea independent of its antibacterial effect. It does not act as an antifungal, stimulate lipid synthesis, or block H1 receptors. This anti-inflammatory mechanism underlies its steroid-sparing role.